Provider advocates celebrated—with some reservations—the recently issued final rule reshaping the Administrative Dispute Resolution (ADR) process for 340B stakeholders. On [...] …
Category: Regulatory
Federal regulators recently said any decision on whether to provide Medicare Advantage (MA) plans funds to reimburse hospitals for past [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Breaking News
HRSA Issues Final Regulations Revamping Process to Resolve Disputes Between 340B Providers and Manufacturers
The federal government issued the final rule early Thursday to implement a long-anticipated revision to the 340B Administrative Dispute Resolution [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal appeals court panel pressed both the AIDS Healthcare Foundation and (AHF) and Apexus, the 340B prime vendor, to [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Medicare paid hospitals substantially more—almost $4 billion in aggregate—than the 340B ceiling price costs for dozens of single-source drugs, biologics [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
After missing its self-imposed deadline of the end of 2023, the White House this week completed its review to implement [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Health Resources and Services Administration (HRSA) on Monday announced Chantelle Britton as its next Office of Pharmacy Affairs (OPA) [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A recent analysis of the increasing annual total number of drug manufacturer refunds to 340B covered entities notes they are [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The dozens of health systems suing the federal government over the reversal of a pandemic-era 340B child site registration waiver [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drugmakers Amgen and Johnson & Johnson have announced they will provide refunds to 340B providers on past purchases of multiple [...] …